Pembrolizumab-induced acute exacerbation of hepatitis D.
Sign Up to like & getrecommendations! Published in 2022 at "Zeitschrift fur Gastroenterologie"
DOI: 10.1055/a-1934-1940
Abstract: A 55-year-old man was treated with combined immunochemotherapy (pembrolizumab, carboplatin and pemetrexed) because of non-small cell lung cancer (NSCLC). In addition, the patient had a medical history of chronic hepatitis B/D virus infection and cystic… read more here.
Keywords: pembrolizumab induced; exacerbation hepatitis; hepatitis; treatment ... See more keywords